Have a personal or library account? Click to login
Imaging in nasopharyngeal carcinoma: the value of 18-Florine Fluorodeoxyglucose PET/CT in comparison to conventional imaging modalities CT and MRI Cover

Imaging in nasopharyngeal carcinoma: the value of 18-Florine Fluorodeoxyglucose PET/CT in comparison to conventional imaging modalities CT and MRI

Radiology and Oncology
Volume 43 (2009): Issue 4 (December 2009)
By: Abdul Nordin,  Simona Secondino,  Noraini Rahim,  Paolo Pedrazzoli,  Salvatore Siena,  Claudio Rossetti and  Tahir Aris  
Open Access
|Oct 2009

References

  1. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001; 345: 1877-82.10.1056/NEJMoa011610
    Search in Google Scholar
  2. Mutirangura A, Tanunyutthawongese C, Pornthanakarem W, Kerekhanjanarong V, Sriuranpong V, Yenrundi S, et al. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Brit J Cancer 1997: 76: 770-6.10.1038/bjc.1997.460
    Search in Google Scholar
  3. Krishna SM, James S, Kattoor J, Balaram P. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin. Jpn J Clin Oncol 2004; 34: 307-11.10.1093/jjco/hyh055
    Search in Google Scholar
  4. Mutirangura A, Pornthanakanem W, Theamboonlers A, Sriuranpong V, Lertsanguansinchi P, Yenrudi S, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 1998; 4: 665-9.
    Search in Google Scholar
  5. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, et al. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 2002; 8: 2612-9.
    Search in Google Scholar
  6. Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol 1990; 28: 2398-402.10.1128/jcm.28.11.2398-2402.1990
    Search in Google Scholar
  7. Macdonald MR, Le KT, Freeman J, Hui MF, Cheung RK, Dosch HM. A majority of inverted sinonasal papillomas carries Epstein-Barr virus genomes. Cancer 1995; 75: 2307-12.10.1002/1097-0142(19950501)75:9<;2307::AID-CNCR2820750920>3.0.CO;2-Z
    Search in Google Scholar
  8. Liavaag PG, Cheung RK, Kerrebijn JD, Freeman JL, Irish JC, Dosch HM. The physiologic reservoir of Epstein-Barr virus does not map to upper aerodigestive tissues. Laryngoscope 1998; 108: 42-6.10.1097/00005537-199801000-00008
    Search in Google Scholar
  9. World Health Organisation International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Summary of data reported and evaluation Epstein-Barr virus Kaposi's sarcoma 1997; 70: 47.
    Search in Google Scholar
  10. Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, et al. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 130-7.10.1016/j.ijrobp.2006.07.012
    Search in Google Scholar
  11. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81.10.2478/v10019-008-0006-4
    Search in Google Scholar
  12. Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, et al. Prognostic significance of the Epstein-Barrvirus, p53, Bcl-2, and surviving in nasopharyngeal cancer. Clin Cancer Res 2006; 12: 5726-32.10.1158/1078-0432.CCR-06-0571
    Search in Google Scholar
  13. Avazpour I, Roslan RE, Bayat P, Saripan MI, Nordin AJ, Raja Abdullah RSA. Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach. Radiol Oncol 2009; 43: 180-86.10.2478/v10019-009-0023-y
    Search in Google Scholar
  14. Feinmesser R, Miyazaki I, Cheung R, Freeman JL, Noyek AM, Dosch HM. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med 1992; 326: 17-21.10.1056/NEJM199201023260103
    Search in Google Scholar
  15. Chan SC, Ng SH, Chang JT, Lin CY, Chen YC, Chang YC, et al. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2006; 33: 1032-40.10.1007/s00259-005-0054-6
    Search in Google Scholar
  16. Ng SH, Joseph CT, Chan SC, Ko SF, Wang HM, Liao CT, et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 2004; 45: 1669-76.
    Search in Google Scholar
  17. Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 2002; 128: 279-82.10.1007/s00432-002-0341-6
    Search in Google Scholar
  18. Kao CH, Shiau YC, Shen YY, Yen RF. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 2002; 94: 1981-6.10.1002/cncr.10400
    Search in Google Scholar
  19. Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 1997; 22: 209-14.10.1046/j.1365-2273.1997.00852.x
    Search in Google Scholar
  20. Kao CH, Chang Lai SP, Chieng PU, Yen RF, Yen TC. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998; 16: 3550-5.10.1200/JCO.1998.16.11.3550
    Search in Google Scholar
  21. Kao CH, Tsai SC, Wang JJ, Ho YJ, Yen RF, Ho ST. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Cancer 2001; 92: 434-9.10.1002/1097-0142(20010715)92:2<;434::AID-CNCR1339>3.0.CO;2-O
    Search in Google Scholar
  22. Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 2002; 128: 279-82.10.1007/s00432-002-0341-6
    Search in Google Scholar
  23. Krause BJ, Beyer T, Bockisch A, Delbeke D, Kotzerke J, Minkov V, et al. FDG-PET/CT in oncology. German guideline. Nuklearmedizin 2007; 46: 291-301.10.3413/nukmed-282
    Search in Google Scholar
  24. Chua DT, Sham JS, Kwong DL, Au GK, Choy DT. Retropharyngeal lymphadenopathy in patients with nasopharyngeal carcinoma: a computed tomography-based study. Cancer 1997; 9: 869-77.10.1002/(SICI)1097-0142(19970301)79:5<;869::AID-CNCR1>3.0.CO;2-7
    Search in Google Scholar
  25. Gutzeit A, Antoch G, Kühl H, Egelhof T, Fischer M, Hauth E, et al. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology 2005; 234: 227-34.10.1148/radiol.234103155415564390
    Search in Google Scholar
  26. Paulus P, Sambon A, Vivegnis D, Hustinx R, Moreau P, Collignon J, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998; 108: 1578-83.10.1097/00005537-199810000-000299778305
    Search in Google Scholar
  27. Ewald K, Mikosch P, Gallowitsch HJ, Kohlfurst S, Lind P. The value of imaging methods with emphasis on PET/CT in head and neck tumours: a comparison between a novel diagnostic regime using 18F-FDG PET and conventional techniques - own results and literature review. Imaging Decisions 2007; 2: 24-32.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10019-009-0026-8 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 247 - 257
Published on: Oct 26, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
positron emission tomography,
computed tomography,
magnetic resonance imaging,
nasopharyngeal carcinoma,
follow-up
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2009 Abdul Nordin, Simona Secondino, Noraini Rahim, Paolo Pedrazzoli, Salvatore Siena, Claudio Rossetti, Tahir Aris, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 43 (2009): Issue 4 (December 2009)